GPRK Q1 2026 Earnings Positive EPS of 036 Reported Amid Limited Visibility FCPT Q1 2026 Earnings EPS Misses Estimates Amidst Stable Portfolio Fundamentals ARCB Q1 2026 Earnings EPS Surprise of 1536 Drives Stock Higher InMed Pharmaceuticals Q3 2025 Earnings Net Loss Widens Amid Pipeline Focus Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss Weighs on Sentiment NXST Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance